The Global Toxoplasmosis Treatment Industry addresses the therapeutic needs of patients infected with Toxoplasma gondii, a widespread intracellular parasitic protozoan. While infection often remains asymptomatic in healthy individuals, it poses severe, life-threatening risks to two primary patient groups: the immunocompromised (such as HIV/AIDS or transplant patients) and neonates (re... https://www.databridgemarketresearch.com/reports/global-toxoplasmosis-treatment-market?utm_source=onkar&utm_medium=organic&utm_campaign=hc&utm_id=global-toxoplasmosis-treatment-market